Enlarge / Elizabeth Holmes (C), founder and former CEO of blood testing and life sciences company Theranos, walks with her mother Noel Holmes and partner Billy Evans into the federal courthouse for her sentencing hearing on November 18, 2022, in San Jose, California. (credit: Getty | Amy Osborne )

Elizabeth Holmes has been sentenced to 11.25 years in federal prison, plus three years of supervision for her conviction in January on four counts of defrauding investors of her failed blood-testing company, Theranos. Restitution in the case will be determined at a later hearing, not yet set.

The sentencing is less than the maximum of 20 years set by federal sentencing guidelines, but still more than the nine-year prison sentence recommended by the probation officer in Holmes' case.

Federal prosecutors had sought 15 years of imprisonment and for Holmes, 38, to pay roughly $804 million in restitution to defrauded investors. Holmes' lawyers, meanwhile, requested just 18 months of house arrest and argued that she has "essentially no assets" and could not pay a nine-figure fine.

Enlarge / Former Theranos CEO Elizabeth Holmes (center) arrives at federal court with her father, Christian Holmes, and partner, Billy Evans, on October 17 in San Jose, California. Holmes appeared in federal court related to an attempt to overturn her fraud conviction. (credit: Getty | Justin Sullivan )

Elizabeth Holmes, the disgraced founder of the defunct blood-testing startup Theranos, lost her bid for a new fraud trial. That's despite the dramatic twist in the case last month, with Holmes winning a last-minute hearing over a bizarre incident in which the government's star witness against her showed up distraught and disheveled at her home.

Holmes, who was convicted in January on four counts of criminal fraud for deceiving investors, is now scheduled for sentencing on November 18.

In a ruling filed late Monday, US District Judge Edward Davila flatly denied Holmes' motions for a new trial, concluding that they didn't include new information relating to her case or establish any misconduct by government prosecutors.

Enlarge / Elizabeth Holmes, founder of Theranos Inc., arrives at federal court in San Jose, California, on Thursday, September 1. (credit: Getty | Bloomberg )

On the brink of sentencing for her four fraud convictions in January , disgraced Theranos founder Elizabeth Holmes will get a new evidentiary hearing in which the judge in the criminal case will weigh "limited, but serious" allegations that government prosecutors manipulated testimony from a key witness, former Theranos lab director Adam Rosendorff.

The new evidentiary hearing is scheduled for October 17, the day on which Holmes was previously set to be sentenced. Her sentencing is now delayed, with rescheduling possible between November and January.

The new evidentiary hearing stems from an unusual incident in August, in which an allegedly distraught Rosendorff showed up at Holmes' home to try to talk with her. According to court documents, Rosendorff first called Holmes' lawyer at around 5 pm on August 8 and left a voicemail in which he asked for an arranged meeting with Holmes at her house. The lawyer has a recording of the voicemail. An hour or so after leaving that message, Rosendorff—having not heard back from the lawyer—showed up at Holmes' home. Holmes did not speak with Rosendorff, but her partner, William Evans, did.

Enlarge (credit: Justin Sullivan / Staff | Getty Images North America )

After nearly five days of jury deliberations, a unanimous verdict has been reached in the trial of former Theranos president and chief operating officer Ramesh "Sunny" Balwani. Balwani was found guilty of all 12 charges of wire fraud and conspiracy to commit wire fraud.

New York Times reporter Erin Griffith tweeted that the courtroom drew the case’s biggest crowd while the verdict was read. Balwani faces a maximum sentence of up to 20 years in prison and fines of $250,000 per wire fraud and conspiracy count, plus restitution.

In 2018, Balwani was indicted, along with Theranos founder Elizabeth Holmes, for allegedly defrauding investors, doctors, and patients who bought into $9 billion-startup Theranos’ simplified blood-testing technology that proved too good to be true.